Susceptibility of Treatment-Naive Hepatitis C Virus (HCV) Clinical Isolates to HCV Protease Inhibitors

In order to assess the natural variation in susceptibility to hepatitis C virus (HCV) NS3 protease inhibitors (PIs) among untreated HCV patient samples, the susceptibilities of 39 baseline clinical isolates were determined using a transient-replication assay on a panel of HCV PIs, including two α-ke...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Bae, Andrew, Sun, Siu-Chi, Qi, Xiaoping, Chen, Xiaowu, Ku, Karin, Worth, Angela, Wong, Kelly A., Harris, Jeanette, Miller, Michael D., Mo, Hongmei
Format: Artigo
Langue:Inglês
Publié: American Society for Microbiology (ASM) 2010
Sujets:
Antiviral Agents
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2981235/
https://ncbi.nlm.nih.gov/pubmed/20855726
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00777-10
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires